BigPatents India

From the above mentioned three procedures, the finished products from Procedure-1 has given the optimum result and in our opinion the concentrations of Sucralfate-500 mg and Aceclofenac-100 mg are best suited for use but however these ingredients can be mixed in other higher and lower concentrations too which will yield somewhat similar results. Better patient compliance of the 2 principal ingredients used in the present invention : It has been found that Aceclofenac provides relief and treatment from pain and inflammation of various etiology being a potent NSAID and this present invention also contains Sucralfate the mucoprotective anti-ulcerrant along with Aceclofenac resulting in a better patient compliance. This invention is effective in rheumatic and musculo skeletal disorders without affecting the gastric mucosa. As the present invention may be embodied in several forms without departing from the spirit or essential characteristics thereof, it should also be understood that the above-described examples are not limited by any of the details of the foregoing description, unless otherwise specified, but rather should be construed broadly within its spirit and scope as defined in the appended claims and, therefore, all changes and modifications that fall within the meets and bounds of the claims, or equivalences of such meets and bounds are therefore intended to be embraced by the appended claims.